Skip to main content
Premium Trial:

Request an Annual Quote

CLARIFICATION: University of Washington Will Use Amersham Proteomics, Microarray Systems

This brief mistakenly reported that Amersham's 2-D gel system lets researchers compare as many as three proteins at a time. In fact, the system allows for simultaneous comparisons of up to three protein samples.

NEW YORK, March 11 - University of Washington researchers will use Amersham proteomics and mRNA expression systems in order to explore cell function, the two said today.


Amersham will provide the UW researchers with its 2-D Differential In-Gel Electrophoresis system and DNA microarray platform. Its 2-D gel system allows for simultaneous comparisons of up to three protein samples at a time.


The system will be located in the lab of Roger Bumgarner, director of UW's Center for Expression Arrays.


Bumgarner, who is a research scientist in the university's department of molecular biotechnology, is now working on a high throughput genotyping system that makes use of simple sequence repeat polymorphisms. He is also developing software to be used  for the analysis of differential hybridizations on high density DNA arrays.


Financial details of the Amersham deal were not disclosed.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.